MetaCap

PRF Technologies (PRFX) vs Sunshine Biopharma (SBFM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Sunshine Biopharma is the larger company by market cap ($1.8 million vs $1.7 million), about 1.1 times the size. Sunshine Biopharma converts more of its revenue into profit, with a net margin of -16.5% versus -29541.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

PRFX-45.79%SBFM+218.57%
+398%+149%-101%
Oct 7, 20261 yearNov 20, 2026
PRFX-45.86%SBFM+560.15%
+809%+356%-97%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

PRFX versus SBFM key metrics
MetricPRFXSBFM
Share price$0.4758$2.23
Market cap$1.66M$1.84M
1-day change-23.68%-5.11%
Forward P/E—0.01
EPS (TTM)$-4.09$-620.60
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$17.00K$36.31M
Revenue growth (YoY)—+4.11%
Net income (latest FY)$-5.02M$-5.98M
Gross margin-311.76%33.76%
Operating margin-30129.41%-17.15%
Net margin-29541.18%-16.46%
52-week high$7.95$464.00
52-week low$0.46$2.23
Distance from 52-week high-94.02%-99.52%
Analyst consensus—none
Avg. price target upside—+2411.21%
Average volume228.55K301.48K
Shares outstanding3.50M823.77K
Employees650
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Sunshine Biopharma is more profitable, keeping -16.5 cents of every revenue dollar as net income versus -29541.2 cents for PRF Technologies.

About PRF Technologies

PRFX stock →

PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

About Sunshine Biopharma

SBFM stock →

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.

Health Care · Biotechnology: Pharmaceutical Preparations · 50 employees

PRFX vs SBFM FAQ

Which is bigger, PRF Technologies or Sunshine Biopharma?

Sunshine Biopharma (SBFM) is larger, with a market capitalization of $1.84M compared with $1.66M for PRF Technologies (PRFX).

Are PRF Technologies and Sunshine Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons